First published · Last updated
P2.06.10 Title: Prognostic Impact of TP53 Co-Mutations with EGFR vs KRAS in Advanced Non-Small Cell Lung Cancer: A cBioPortal Analysis
A journal article reports an analysis using cBioPortal to compare how TP53 co-mutations alongside EGFR versus KRAS relate to prognosis in advanced non-small cell lung cancer. The excerpt lists Elsevier BV as publisher and identifies the item as a journal article published 2025-10-01.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 2/10
Why it matters
The study addresses prognostic biomarkers relevant to advanced non-small cell lung cancer.

